Perrine Vuagnat

Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies

Capucine Baldini, P. Martin Romano, Anne-Laure Voisin et al. · European Journal of Cancer · 2020 · 80 citations

Aging, Immune Regulation, Immunology +16

Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients

Clémence Basse, Sarah Diakite, Vincent Servois et al. · JNCI Cancer Spectrum · 2020 · 59 citations · Full text

Cytogenetic studies of human testicular germ cell tumours

C.D. DeLozier-Blanchet, H. Walt, Eric Engel et al. · International Journal of Andrology · 1987 · 56 citations

Cytogenetics, Such Testicular Tumours, Chromosomal Content +16

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types

Patricia Martin‐Romano, Eduardo Castañón, Samy Ammari et al. · Cancer Medicine · 2020 · 56 citations · Full text

A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer

Nuria Kotecki, Perrine Vuagnat, Bert H. O’Neil et al. · Journal of Immunotherapy · 2021 · 31 citations